VIM and urinary bladder carcinoma: Immunoprecipitation using anti-DYKDDDDK and anti-HA beads confirmed the interactions of FAM171B with vimentin (Figure S4E) and HNRNPU (Figure S4F) in MB49 mouse bladder cancer cells.